Radiotherapy in combination with immune checkpoint inhibitors

Dirk De Ruysscher*, Kobe Reynders, Evert Van Limbergen, Maarten Lambrecht

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)105-111
Number of pages7
JournalCurrent Opinion in Oncology
Volume29
Issue number2
DOIs
Publication statusPublished - Mar 2017

Keywords

  • cancer
  • checkpoint inhibitors
  • immune therapy
  • radiation
  • radiotherapy
  • CELL LUNG-CANCER
  • IMMUNOTHERAPY
  • IRRADIATION
  • DOCETAXEL
  • PEMBROLIZUMAB
  • MULTICENTER
  • IPILIMUMAB
  • NIVOLUMAB
  • RADIATION
  • MICE

Cite this